Company Filing History:
1 out of 1,382 
1 out of 818 
Years Active: 2017
Title: Ann Thor - Innovator in Cancer Treatment
Introduction
Ann Thor is a prominent inventor based in Aurora, CO (US), known for her groundbreaking work in the field of cancer treatment. She has made significant contributions to the medical community, particularly in the fight against triple-negative breast cancer. Her innovative approach has the potential to change the landscape of cancer therapies.
Latest Patents
Ann Thor holds a patent for a method of treating triple-negative breast cancer using AMPI-109. This targeted approach reveals the remarkable 'cancer-specific' characteristics of AMPI-109. The compound demonstrates a striking capability to inhibit the proliferation of triple-negative breast cancer cells and induce apoptosis in these cells. Notably, the growth inhibitory effect of AMPI-109 is independent of VDR. Furthermore, AMPI-109 can be coupled with other oncolytic agents to enhance treatment efficacy for patients suffering from triple-negative breast cancer.
Career Highlights
Throughout her career, Ann has worked with esteemed institutions such as the University of Colorado and Boston University. Her research and innovations have garnered attention and respect within the scientific community.
Collaborations
Ann has collaborated with notable colleagues, including Hamid Gari and Jim Lambert, to advance her research and develop effective cancer treatments.
Conclusion
Ann Thor's contributions to cancer treatment through her innovative patent for AMPI-109 exemplify her dedication to improving patient outcomes. Her work continues to inspire future research in the field of oncology.